ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic potential
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
NIAID scientists found Infectious SARS-CoV-2 in patient blood
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
Scientists unveiled complete cell map of a whole mammalian brain
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
Allen Institute scientists and partners unveiled first complete cellular map of adult mouse brain
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
CDC announced Rocky Mountain spotted fever in people traveling to the U.S. from Tecate, Mexico
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
Biotechnology | CRISPR | FDA | Genomics | Life Science News | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
The University of Virginia broke ground on Paul and Diane Manning Institute of Biotechnology
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
BioNTech and Australiaï¾’s State of Victoria signed agreement on strategic partnership to strengthen mRNA rcosystem
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
FDA released summary report on antimicrobial drugs sold or distributed for use in all food-producing animal species
On Dec. 7, 2023, the U.S. Food and Drug Administration reported that of the more than 116 medically…
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
University of Missouri research reactor announced commercial shipments of radioisotope for cancer treatment
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
Home Test to Treat program extended nationwide offers testing, telehealth and treatment for COVID-19 and flu
On Dec. 6, 2023, the federal government announced it had expanded the Home Test to Treat program, an…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
Novartis received FDA approval for Fabhaltaï¾® (iptacopan) as the first oral monotherapy for adults with PNH
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaï¾® (iptacopan)…
University of Wisconsin-Madison sewer sleuthing, air vacuuming scientists keep tabs on COVID-19
On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…
Global donors pledged over US $777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
WHO announced influenza A(H1N2) variant virus infection in the Great Britain and Northern Ireland
On Dec. 1, 2023, the World Health Organization (WHO) announced that the International Health Regulations National Focal Point…
USDA deregulated corn developed using genetic engineering
On Nov. 30, 2023, the U.S. Department of Department of Agricultureï¾’s (USDA) Animal and Plant Health Inspection Service…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
Scientists build tiny biological robots from human cells
On Nov. 30, 2023, researchers at Tufts University announced they had created tiny biological robots that they call…
New bacterial species isolated from a hydrothermal vent throws light on their evolution
On Nov. 30, 2023, researchers at Hokkaido University, in collaboration with colleagues at Woods Hole Oceanographic Institution announced…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
WHO announced Avian influenza A (H5N1) cases in Cambodia
On Nov. 29, 2023, the World Health Organization (WHO) announced that between 24 and 25 November 2023, the…
Passenger with measles travelled through Vancouver International Airport
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
Emergent received $75 million contract option from BARDA to procure doses of CYFENDUS (Anthrax Vaccine)
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…